Gyre Therapeutics Inc (GYRE)

Deferred Revenue

$189.00K

Quarterly · Period ending: · USD

GYRE logo

GYRE Deferred Revenue

Latest reported$189.00K
GYRE Quarterly Deferred Revenue ($2.85M → $189.00K)
High-resolution chart · PNG

GYRE deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
189,000
99,000
111,000
154,000
95,000
123,000
156,000
76,000
97,000
75,000
79,000
0
0
0
167,000
0
0
0
230,000
853,000
2,037,999
1,332,000
1,983,000
764,000
330,000
0
15,000,000
0
0
0
0
0
0
0
212,000
530,000
848,000
259,000
283,000
401,000
437,000
438,000
438,000
438,000
0
0
0
0
25,000
61,000
-2,149,000
-2,948,000
-3,073,000
-3,374,000
2,357,000
2,357,000
3,273,000
35,917,000
57,714,000
74,449,000
73,487,000
75,931,000
81,710,000
84,138,000
86,336,000
77,162,000
77,285,000
42,000
5,143,000
6,120,000
6,521,000
6,520,840
6,520,840
6,478,772
6,520,840
4,863,387
2,250,000
2,384,215
2,484,877
3,010,539
1,904,202
1,250,000
2,849,747
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.